Ethic Inc. 10x Genomics, Inc. Transaction History

Ethic Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$50.96 - $58.72 $95,142 - $109,630	-1,867 Reduced 27.49%	4,925 $275,000
Q1 2023 May 12, 2023	SELL	$35.33 - $55.79 $28,581 - $45,134	-809 Reduced 10.64%	6,792 $378,000
Q4 2022 Feb 14, 2023	BUY	$24.4 - $41.3 $185,464 - $313,921	7,601 New	7,601 $276,000
Q2 2022 Aug 10, 2022	SELL	$36.95 - $82.41 $111,515 - $248,713	-3,018 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $52,135 - $136,459	936 Added 44.96%	3,018 $230,000
Q4 2021 Feb 14, 2022	BUY	$135.05 - $182.59 $36,868 - $49,847	273 Added 15.09%	2,082 $310,000
Q3 2021 Nov 15, 2021	SELL	$145.58 - $192.14 $13,247 - $17,484	-91 Reduced 4.79%	1,809 $263,000
Q2 2021 Aug 10, 2021	BUY	$134.22 - $202.37 $255,018 - $384,503	1,900 New	1,900 $372,000

286

95.8M

162K

107K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.51B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

Stay updated on Ethic Inc. with notifications on news.